Mariner Investment Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

Mariner Investment Group’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-17,700	Closed	-$680K	–	138
2016 Q2	$680K	Sell	17,700 -21,300	-55%	-$884K	0.23%	90
2016 Q1	$1.49M	Buy	39,000 +6,000	+18%	+$209K	0.41%	74
2015 Q4	$1.45M	Sell	33,000 -2,000	-6%	-$99.2K	0.32%	96
2015 Q3	$1.42M	Buy	35,000 +11,000	+46%	+$482K	0.29%	96
2015 Q2	$1.28M	Buy	24,000 +10,500	+78%	+$557K	0.33%	96
2015 Q1	$819K	Sell	13,500 -19,200	-59%	-$932K	0.22%	105
2014 Q4	$1.71M	Buy	+32,700	New	+$1.46M	0.29%	88

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Mariner Investment Group's JUNO Position: Q3 2016 in Review

Mariner Investment Group sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2016, closing a stake of 17,700 shares — an estimated $680K sold.

Mariner Investment Group first reported a position in JUNO in Q4 2014 and held it in 7 quarters. The position peaked at $1.71M in Q4 2014. 169 funds tracked by Wall St. Rank hold JUNO as of Q3 2016.

Mariner Investment Group reported no remaining Juno Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 17,700 Juno Therapeutics, Inc. shares in Q3 2016, an estimated $680K.
Mariner Investment Group first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 7 quarters.
Mariner Investment Group's Juno Therapeutics, Inc. position peaked at $1.71M in Q4 2014.
169 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.